Torrent Pharma will buy a 26% stake in Torrent Urja's ₹7.9 crore hybrid solar-wind project in Gujarat, aiming to cut electricity costs and boost profitability over time. Analyst Mayank Chandel called it a "buying a house vs rent" move. He noted the stock is consolidating in a symmetrical triangle, trading above key EMAs, with a breakout awaited. Shares are up 4.7% YTD.